{
    "nct_id": "NCT03263780",
    "official_title": "High-Resolution, 18F-fluciclovine PET-MRI for Mapping Prostate Cancer in Patients Considering Focal High-Intensity Focused Ultrasound (HIFU) Therapy",
    "inclusion_criteria": "* Prostate biopsy consisting of â‰¥ 10 tissue cores sampled\n* PSA </=20 ng/mL\n* cT1-cT2c\n* Either overall gleason score >/= 7 with Gleason grade 4 or 5 component localized to one lobe (i.e. right or left) OR overall Gleason score 6 with >/= half of systematic biopsy cores positive and >/= 50% of core involvement in at least one core\n* Patient considering focal HIFU therapy\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Previous local therapy for prostate cancer\n* Inability to receive PET tracer\n* Inability to receive MRI\n* Suggestion of extracapsular extension or seminal vesicle invasion on imaging\n* Estimated creatinine clearance <45 mL/min (Cockcroft-Gault equation)\n* Any other condition which, in the investigator's option, may make the patient a poor candidate for participation in a clinical trial.",
    "miscellaneous_criteria": ""
}